Glaukos eyes FDA approval for ocular therapy after Phase III win

Glaukos eyes FDA approval for ocular therapy after Phase III win

Submitted by admin on October 17, 2024 - 8:22pm
Source: 
Clinical Trials Arena
News Tags: 
Glaukos
FDA
clinical trials
keratoconus
Epioxa
Headline: 
Glaukos eyes FDA approval for ocular therapy after Phase III win
snippet: 

The company’s keratoconus medication, Epioxa, was effective in a Phase III trial, with plans to file for submission with the US Food and Drug Administration (FDA).

Do Not Allow Advertisers to Use My Personal information